Richard A. Flavell

Richard A. Flavell
Richard A. Flavell
Born	August 23, 1945
Alma mater	University of Hull;
Awards	Colworth Medal (1980) ; William B. Coley Award (2012)
	Scientific career
Institutions	Yale School of Medicine; Biogen; National Institute for Medical Research; University of Amsterdam;

Richard Anthony Flavell (born 23 August 1945 in Chelmsford, Essex), PhD, FRS is an English molecular biologist, and Sterling Professor of Immunobiology, at Yale School of Medicine where he uses transgenic and gene-targeted mice to study Innate and Adaptive immunity, T cell tolerance and activation in immunity and autoimmunity, apoptosis, and regulation of T cell differentiation.[1] He is an investigator at the Howard Hughes Medical Institute.[2] In 2013, Flavell received the Vilcek Prize in Biomedical Science.[3] In July 2016, Flavell received an honorary doctorate degree from the University of Hull.[4] He is an honorary member of the British Society for Immunology.[5]

Life

He earned a Ph.D. from University of Hull in 1970. He studied at the University of Amsterdam, and the University of Zurich, where he studied with Charles Weissmann. He taught at University of Amsterdam from 1974–1979, then headed the Laboratory of Gene Structure and Expression at the National Institute for Medical Research, Mill Hill, London from 1979–82. Following a move to Biogen in 1982, he became the President and Chief Scientific Officer of Biogen until 1988, when he moved to Yale.[6]

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.